Metabolism of 2-ethylhexanoic acid administered orally or dermally to the female Fischer 344 rat1

Author： English J. C. Deisinger P. J. Guest D.

ISSN： 1366-5928

Source： Xenobiotica, Vol.28, Iss.7, 1998-07, pp. : 699-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

1. Excretion balance studies were conducted with 2-ethylhexanoic acid (EHA) in the female Fischer 344 rat following single high (1 g kg) or low (0.1 g kg) oral doses of [2- Chexyl]EHA,following repeated oraldosing with unlabelled EHA and a final[ C]EHAoral dose at the low dose level, following dermal exposure with a high (1 g kg) and low (0.1 g kg) applied dose of [ C]EHA, and following a 1 mg kg i.v. dose of [ C]EHA. 2. Oral, i.v. and dermal doses were eliminated rapidly, predominantly in the urine during the first 24 h following dosing. 3. After oral dosing of 0.1 g kg, the mean peak blood level was 85.1 mu g equivalents EHA g. Maximum blood concentrations were detected at either 15 or 30 min in individual animals. After dermal application of 0.1 g kg, the mean peak blood level of 7.9 mu g equivalents EHA g was attained at 8 h. 4. Occlusive dermal exposure caused damage to the epidermis in the first 24 h after application and resulted in dermal absorption of 70% relative to i.v. dosing, based on the ratio of percent dose in excreta. 5. Dermal application followed by prompt washing of the skin resulted in recovery of 101.9% from the skin surface and 0.2% in the excreta. 6. The major urinary metabolites were the glucuronide of EHA, 2-ethyl-1,6- hexanedioic acid (namely 2-ethyladipic acid), 2-ethyl-5-hydroxyhexanoic acid, 2-ethyl-6- hydroxyhexanoicacidandethylketohexanoicacid.Evidencefor metabolismvia beta -oxidation was alsofound,consistent with the incorporationofEHAinto normalcellular intermediary metabolism.